#Japan #Tokyo #Pasha-Chart #TechDoctor #Arteryex

Tech Doctor and Arteryex's Partnership: A Step Towards Integrated Healthcare

TechDoctor, led by President Kazushi Minato and based in Chuo, Tokyo, has recently announced a collaboration with Arteryex, headed by President Lee Dong Young and located in Chiyoda, Tokyo. This partnership aims to utilize the "Pasha-Chart" medical information management app to combine clinical data and biometric data for in-depth health analytics.

Project Overview

The collaboration's primary goal is to merge data obtained through the Pasha-Chart app—such as medication records, health checkup results, and clinical test outcomes—with biological data collected via TechDoctor’s wearable devices that monitor essential health metrics like heart rate, sleep patterns, and activity levels. This integration will allow for a more nuanced and continuous understanding of individual health status.

By harnessing the strengths of both companies, the initiative seeks to develop new digital biomarkers that integrate medical and biometric data, contributing significantly to personalized and preventive healthcare solutions. Initially, they will launch a Proof of Concept (PoC) focused on sleep-related disorders, such as insomnia, from August 2025 to March 2026. The aim is to explore the usefulness of their collaborative data integration and its potential for future research and societal application.

Background and Purpose of Data Integration

Both TechDoctor and Arteryex have made strides in visualizing and analyzing individual health data in their respective fields. Arteryex offers the Pasha-Chart app, which automates the digitization and storage of medical data captured through user-uploaded photos of prescription notes and test results. In parallel, TechDoctor is focused on evaluating the continuity and objectivity of disease changes and treatment effectiveness by launching digital biomarkers based on the data retrieved from wearable devices.

This collaboration is set to create new value by consolidating both sets of data, enabling a multifaceted understanding of health conditions that can detect early signs and promote behavioral changes more effectively. The planned PoC will assess these elements in a targeted manner.

Proof of Concept (PoC) Implementation

The PoC, starting in August 2025, will involve participants from among the users of the Pasha-Chart who agree to join the research initiative. The project aims to collect health information and data from the wearable devices and analyze their interconnections to validate the possibilities of data integration.

PoC Summary

• - Duration: August 2025 - March 2026
• - Participant Target: 100 individuals
• - Eligibility: Users of the Pasha-Chart who consent to participate
• - Objective: Investigate the integration of medical information and biometric data to identify trends and gauging usability for future societal deployment

Future Prospects

Post-PoC, the insights gained will inform the development of digital biomarkers intended for predicting new diseases. These advancements will enhance solutions for early detection and lifestyle modifications. The partnership also envisions gathering comprehensive medical data—like checkup results and medication via user-friendly mobile platforms—and integrating this with biometric data from wearables and survey responses.

This collaborative environment is poised to serve as a foundation for collecting Real-World Data (RWD), with the potential to generate Real-World Evidence (RWE) that can substantiate therapy outcomes and insights for research and development in pharmaceuticals, food, and healthcare sectors.

Moreover, the companies plan to possibly integrate these digital biomarkers into the Pasha-Chart app, striving for a new health-support model that enhances personalized and preventive healthcare.

About Arteryex and Pasha-Chart

Arteryex embraces the concept of a "Health Bank," allowing patients to manage their healthcare data as an asset, primarily through the Pasha-Chart app. Their services also include development and operation of platforms utilizing medical data for healthcare enhancements, alongside custom system development for medical applications.

About TechDoctor

TechDoctor, with a vision of enhancing health through data, is advancing the societal implementation of digital biomarkers derived from everyday sensing data through wearables. Collaborating with medical, pharmaceutical, and food industry partners, they aim to realize AI-based medical advancements.

In conclusion, this partnership sets a promising trajectory for integrated healthcare, where technology meets personalized medicine, driving forward the future of health management.